Its triple agonism allows simultaneous study of combined GLP-1 + GIP + glucagon effects, experimental dissections impossible with mono-agonists or dual agonists
CCK has been shown to reduce appetite by slowing gastric emptying, while GLP-1 helps to stimulate the release of insulin and promote satiety
Some studies have shown a reduction of the insulin dose and in hypoglycaemic episodes
Specific to the semaglutide QW versus dulaglutide comparison, the difference in the pens used to administer the GLP-1 RAs may have affected adherence and persistence
Third, as GLP-1 receptor agonists become increasingly utilized, understanding their effects on bone health becomes critical, particularly in older adults and postmenopausal women. Burak Altintas, MD Still, the results dont mean that semaglutide is always the best option when it comes to weight loss
Cardiovasc Res 51(1):2129